ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC): This is considered a more aggressive variant in comparison to other breast cancers as it lacks the expression of the usual estrogen receptors (ER), progesterone receptors (PR), or Her2/neu receptors that are usually targeted by chemotherapy treatment [50].